Research Articles | Page 101 | Aplastic Anemia & MDS International Foundation Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Azacitidine in the management of patients with myelodysplastic syndromes. Dec 2012 Ther Adv Hematol myelodysplastic syndromes (MDS)
Eculizumab in the management of paroxysmal nocturnal hemoglobinuria: patient selection and special considerations Aug 2016 Ther Clin Risk Manag paroxysmal nocturnal hemoglobinuria (PNH)
Management of myelodysplastic syndromes after failure of response to hypomethylating agents May 2019 Therapeutic Advances in Hematology myelodysplastic syndromes (MDS)
Treatment options for lower-risk myelodysplastic syndromes. Where are we now? Jan 2021 Therapeutic Advances in Hematology myelodysplastic syndromes (MDS)
One-year efficacy and safety of ravulizumab in adults with paroxysmal nocturnal hemoglobinuria naïve to complement inhibitor therapy: open-label extension of a randomized study Oct 2020 Therapeutic Advances in Hematology paroxysmal nocturnal hemoglobinuria (PNH)
Ravulizumab: a novel C5 inhibitor for the treatment of paroxysmal nocturnal hemoglobinuria Sep 2019 Therapeutic Advances in Hematology paroxysmal nocturnal hemoglobinuria (PNH)
The dysfunction of platelets in paroxysmal nocturnal hemoglobinuria Jul 2016 Thromb Res paroxysmal nocturnal hemoglobinuria (PNH)
Aplastic anemia and risk of deep vein thrombosis and pulmonary embolism: A nationwide cohort study Jan 2017 Thromb Res aplastic anemia
Anti-Complement Treatment in Paroxysmal Nocturnal Hemoglobinuria: Where we Stand and Where we are Going Feb 2014 Transl Med UniSa paroxysmal nocturnal hemoglobinuria (PNH)
Immunological derangement in hypocellular myelodysplastic syndromes Feb 2014 Transl Med UniSa myelodysplastic syndromes (MDS)
Share with addtoany.com.